Evidence map›Paper›PMID 34588475›Full record

ArticleScientific reports2021

Voiding defects in acute radiation cystitis driven by urothelial barrier defect through loss of E-cadherin, ZO-1 and Uroplakin III.

Bernadette M M Zwaans, Alexander L Carabulea, Sarah N Bartolone, Elijah P Ward, Michael B Chancellor, Laura E Lamb

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. KRT5Stem cell research & therapy · 2025
    Article
  6. Article
  7. Article
  8. What do we really know about the external urethral sphincter?Continence (Amsterdam, Netherlands) · 2024
    Review
  9. Article
  10. Prevention of Radiation-Induced Bladder Injury: A Murine Study Using Captopril.International journal of radiation oncology, biology, physics · 2023
    Article
  11. Article
  12. Article
  13. Zonula Occludens Proteins Signaling in Inflammation and Tumorigenesis.International journal of biological sciences · 2023
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bernadette M M ZwaansBeaumont Health System, Medical Office Building, 3535 W. 13 Mile Road, Suite 438, Royal Oak, MI, 48073, USA. bernadette.zwaans@beaumont.org.
Alexander L CarabuleaBeaumont Health System, Medical Office Building, 3535 W. 13 Mile Road, Suite 438, Royal Oak, MI, 48073, USA.
Sarah N BartoloneBeaumont Health System, Medical Office Building, 3535 W. 13 Mile Road, Suite 438, Royal Oak, MI, 48073, USA.
Elijah P WardBeaumont Health System, Medical Office Building, 3535 W. 13 Mile Road, Suite 438, Royal Oak, MI, 48073, USA.
Michael B ChancellorBeaumont Health System, Medical Office Building, 3535 W. 13 Mile Road, Suite 438, Royal Oak, MI, 48073, USA.
Laura E LambBeaumont Health System, Medical Office Building, 3535 W. 13 Mile Road, Suite 438, Royal Oak, MI, 48073, USA.

Funding

Cancer Survivorship Research and Training in Radiation CystitisK01DK114334 · NIDDK · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI ZWAANS, BERNADETTE MARGARETHA MARIA · 2018 to 2020
$444k
NIDDK NIH HHS K01 DK114334
6 · The paper itself

Abstract

Long term-side effects from cancer therapies are a growing health care concern as life expectancy among cancer survivors increases. Damage to the bladder is common in patients treated with radiation therapy for pelvic cancers and can result in radiation (hemorrhagic) cystitis (RC). The disease progression of RC consists of an acute and chronic phase, separated by a symptom-free period. Gaining insight in tissue changes associated with these phases is necessary to develop appropriate interventions. Using a mouse preclinical model, we have previously shown that fibrosis and vascular damage are the predominant pathological features of chronic RC. The goal of this study was to determine the pathological changes during acute RC. We identified that radiation treatment results in a temporary increase in micturition frequency and decrease in void volume 4-8 weeks after irradiation. Histologically, the micturition defect is associated with thinning of the urothelium, loss of urothelial cell-cell adhesion and tight junction proteins and decrease in uroplakin III expression. By 12 weeks, the urothelium had regenerated and micturition patterns were similar to littermate controls. No inflammation or fibrosis were detected in bladder tissues after irradiation. We conclude that functional bladder defects during acute RC are driven primarily by a urothelial defect.

Indexed as

AnimalsCadherinsCystitisFemaleHumansMicePelvic NeoplasmsRadiation Injuries, ExperimentalUrinary BladderUrinationUroplakin IIIUrotheliumZonula Occludens-1 ProteinCadherinsCdh1 protein, mouseTjp1 protein, mouseUpk3a protein, mouseUroplakin IIIZonula Occludens-1 Protein

Identifiers

PMID34588475
PMCPMC8481534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.